```html
FDA Pre-Submission (Q-Sub) Package for Medical Devices
Planning to submit a medical device to the US Food and Drug Administration (FDA)? Early regulatory feedback can help manufacturers understand FDA's expectations, clarify technical questions, and plan appropriate testing and documentation before making a formal submission.
The FDA Pre-Submission (Q-Sub) Package from Cosmetic Compliance Nest provides regulatory documentation support to help medical device manufacturers prepare a Pre-Submission request, organise technical questions, and present relevant device information for FDA feedback.
A well-prepared Q-Submission can help identify areas requiring further discussion before a future 510(k), De Novo, PMA, or other applicable regulatory submission. The suitability of the process depends on the device, the questions being asked, and the relevant FDA programme.
What Is an FDA Pre-Submission (Q-Sub)?
An FDA Pre-Submission, commonly called a Pre-Sub, is a type of Q-Submission through which a medical device sponsor can request FDA feedback on specific regulatory, scientific, or technical questions before making a planned marketing submission.
Depending on the project, manufacturers may seek feedback on testing strategies, nonclinical study protocols, clinical study design, proposed regulatory pathways, or other issues relevant to the development and evaluation of a medical device.
The objective is to support a more informed regulatory strategy by giving FDA an opportunity to provide feedback on clearly defined questions. FDA feedback is based on the information provided and does not guarantee the outcome of a later marketing submission.
What Does Our FDA Q-Sub Package Cover?
- Initial Regulatory Assessment: Review the device concept, intended use, development stage, and planned FDA regulatory pathway.
- Pre-Submission Strategy: Help identify the key issues and questions for which FDA feedback may be useful.
- Question Development: Assist with preparing clear, focused questions supported by relevant background information.
- Device Background Documentation: Organise applicable device descriptions, intended use information, technological characteristics, and development details.
- Testing Strategy Discussion: Help document proposed nonclinical or performance testing approaches where relevant to the questions being submitted.
- Clinical and Scientific Questions: Assist with organising applicable questions concerning clinical study planning or scientific evidence, subject to the agreed scope.
- Q-Submission Document Preparation: Support preparation and organisation of the applicable Pre-Submission package.
- Submission Readiness Review: Review the draft package for clarity, completeness, and consistency before submission by the responsible sponsor.
The final scope depends on the device, the questions requiring feedback, the available evidence, and the agreed service deliverables. Specialised scientific, statistical, clinical, or laboratory work may require separate support.
When Should You Consider an FDA Pre-Submission?
A Pre-Submission may be useful when a manufacturer needs to discuss important regulatory or technical questions before investing in further development or preparing a marketing submission.
- Uncertain Regulatory Pathway: When you need to discuss a proposed pathway or specific regulatory questions with FDA.
- 510(k) Planning: When preparing a Traditional 510(k) and seeking feedback on selected testing or technical issues.
- De Novo Planning: When developing a device for which a De Novo request may be considered and early feedback could help address specific questions.
- Testing Protocols: When you want to seek feedback on proposed nonclinical testing or validation approaches.
- Clinical Study Planning: When feedback on aspects of a proposed clinical investigation may be helpful.
- Novel Technology: When the device incorporates new technology or raises technical questions that may benefit from early regulatory discussion.
A Q-Submission is not necessary for every medical device project. The decision to request FDA feedback should be based on the specific questions, project stage, and regulatory strategy.
Types of Questions That May Be Included
- Regulatory Pathway Questions: Questions about the proposed approach to a future FDA marketing submission.
- Performance Testing: Questions about proposed bench testing, test methods, acceptance criteria, or supporting evidence.
- Biocompatibility: Questions about the planned biological evaluation approach, where applicable.
- Sterilisation and Packaging: Questions about proposed validation approaches or supporting evidence, where relevant.
- Software and Cybersecurity: Questions about relevant software documentation, verification, validation, or cybersecurity considerations.
- Clinical Evidence: Questions about proposed clinical investigations, study design, or clinical evidence requirements.
- Risk Management: Questions concerning relevant safety risks and the proposed approach to evaluating them.
- Submission Content: Questions about specific documentation or evidence that may be relevant to a planned marketing submission.
Questions should be specific and supported by enough background information for FDA to understand the device, the issue being discussed, and the feedback being requested.
Our FDA Pre-Submission Preparation Process
- Initial Consultation: Review the device, development stage, intended use, and planned regulatory objectives.
- Question Identification: Identify the technical or regulatory issues for which FDA feedback may be beneficial.
- Background Information Review: Review relevant device descriptions, available testing evidence, proposed protocols, and supporting records.
- Question Drafting: Help prepare focused questions and organise the rationale and context for each question.
- Package Preparation: Organise the applicable Q-Submission documentation and supporting information within the agreed scope.
- Readiness Review: Check the draft package for clarity, consistency, and completeness against the applicable requirements.
- Finalisation: Provide the prepared materials for review and approval by the sponsor or authorised submitter before filing with FDA.
Documents and Information You May Need
The information required depends on the purpose of the Pre-Submission and the questions being asked. Relevant documents may include:
- Device name, description, and intended use.
- Device development stage and planned regulatory pathway.
- Available product specifications, drawings, and technological information.
- Relevant predicate or comparable device information, where applicable.
- Existing performance testing, verification, and validation data.
- Proposed testing protocols or study plans requiring FDA feedback.
- Risk management documentation, where available and relevant.
- Applicable software, biocompatibility, sterilisation, or clinical information.
- A list of the specific questions for which FDA feedback is requested.
- Relevant previous FDA correspondence, where applicable.
Not all documents are required for every Q-Submission. The package should be proportionate to the questions and the stage of device development.
Who Can Benefit from This Service?
- Medical device manufacturers planning an FDA marketing submission.
- Start-ups developing new medical technologies.
- Companies preparing for a Traditional 510(k), De Novo, or other applicable regulatory pathway.
- Manufacturers seeking feedback on proposed testing protocols or technical questions.
- Regulatory affairs teams planning discussions with FDA before a formal submission.
- Developers who need to organise their regulatory questions and supporting documentation.
Benefits of an FDA Pre-Submission Package
- Clearer Regulatory Questions: Organise technical and regulatory questions in a structured format.
- Early Planning: Seek feedback on selected issues before finalising a future marketing submission.
- Better Documentation: Present device background information and the rationale for proposed approaches clearly.
- Testing Strategy Support: Prepare focused questions about proposed testing methods or protocols, where relevant.
- Improved Team Coordination: Help align regulatory, engineering, clinical, and quality teams around the issues requiring feedback.
- More Informed Decisions: Use applicable FDA feedback as an input to future regulatory planning.
Understanding FDA Feedback and Next Steps
FDA feedback received through a Pre-Submission is intended to inform discussion and planning around the questions raised. The usefulness of that feedback depends on the information provided, the questions asked, and the context of the device.
Feedback does not constitute FDA clearance, approval, or a guarantee that a future submission will be accepted or receive a favourable decision. Manufacturers remain responsible for meeting all applicable requirements and for the content of subsequent submissions.
Frequently Asked Questions About FDA Pre-Submissions
Visit our dedicated Frequently Asked Questions page for further information about FDA Q-Submissions, Pre-Submission preparation, technical questions, supporting documentation, and regulatory planning.
Request FDA Pre-Submission Support
Do you need to discuss regulatory or technical questions with FDA before submitting your medical device application? Cosmetic Compliance Nest can help assess your objectives and prepare a suitable scope for Q-Submission documentation support.
Share your device details, development stage, planned regulatory pathway, and proposed questions to begin the assessment.
Important Disclaimer
Cosmetic Compliance Nest provides independent regulatory documentation and consultancy services and is not affiliated with or endorsed by the US Food and Drug Administration (FDA). A Pre-Submission is a mechanism for requesting FDA feedback on specific questions and does not guarantee clearance, approval, acceptance of a future submission, or a particular regulatory outcome. FDA feedback is based on the information available during the interaction and should be considered in the context of applicable requirements. The device sponsor remains responsible for the accuracy of the information provided, regulatory decisions, and final submissions. Clinical studies, laboratory testing, specialised scientific assessments, official fees, and other third-party services are excluded unless expressly included in the agreed service scope.